Festive Deal Ca Ix Monoclonal Antibody Now 85% Cheaper [RqsheJy1]
Festive Deal Ca Ix Monoclonal Antibody Now 85% Cheaper [RqsheJy1]: A Powerful Tool for Cancer Diagnosis The Festive Deal Ca Ix Monoclonal Antibody Now 85% Cheaper [RqsheJy1] is a cutting-edge diagnostic tool designed for the identification of clear cell renal cell carcinoma (RCC). This mouse-derived antibody offers high specific
Secure Shopping
100% Safe Guarantee
Free Shipping
On orders over $30
Money-Back
30-Day Guarantee
Festive Deal Ca Ix Monoclonal Antibody Now 85% Cheaper [RqsheJy1]: A Powerful Tool for Cancer Diagnosis
The Festive Deal Ca Ix Monoclonal Antibody Now 85% Cheaper [RqsheJy1] is a cutting-edge diagnostic tool designed for the identification of clear cell renal cell carcinoma (RCC). This mouse-derived antibody offers high specificity and sensitivity, making it an invaluable asset in the medical field. With its ability to detect CA IX, a protein overexpressed in RCC and other cancers, this monoclonal antibody provides a reliable method for early detection and diagnosis. Key features include:- High specificity for human CA IX
- Applications in IHC-P for RCC diagnosis
Product Specifications and Storage Details
The Festive Deal Ca Ix Monoclonal Antibody Now 85% Cheaper [RqsheJy1] is produced using a mouse host, ensuring high-quality and consistent results. It is reactive to human CA IX, making it suitable for use in various diagnostic procedures. This antibody is optimized for immunohistochemistry (IHC-P), allowing for accurate and efficient analysis. Key specifications include:- Host: Mouse
- Reactivity: Human
- Applications: IHC-P
Practical Applications and Target Audience
The Festive Deal Ca Ix Monoclonal Antibody Now 85% Cheaper [RqsheJy1] is an essential tool for pathologists and oncologists involved in the diagnosis of RCC. Its ability to detect CA IX in clear cell renal cell carcinoma provides a valuable diagnostic marker, helping healthcare professionals make informed decisions about patient care. This product is particularly beneficial for patients with a high risk of RCC, as it allows for early detection and intervention. Target audience includes:- Pathologists
- Oncologists
- Patients at risk of RCC
What Our Customers Say
Absolutely no complaints!
It's a very well-made product, great quality and very trustworthy.
- Flora P..
Absolutely no complaints!
The product is just what I was hoping for.
- Emily C..
Absolutely no complaints!
This is a very sophisticated device that remains simple to use.
- Sophisticated_User_Sam.